There remains a need to identify patients who will derive benefits from adjunctive techniques on top of pulmonary vein ...

The observed changes were favorable, but results may have been affected by better-than-normal care in the control arm.

In the trial, 20% of patients didn’t respond well to the PCSK9 inhibitor—could genetic markers be used to tailor therapy?

By targeting the TTR gene directly in the liver, the therapy “has opened up the door” to permanent treatment, says Sarah ...

Two studies presented at AHA show the capacity of AI to improve sonographer accuracy, consistency, and workflow.

In the Swedish survey, many patients said their sexual health was impaired, but few got the information they wanted.

The accuracy of a several popular consumer smart devices for detecting atrial fibrillation (AF) did not improve over a ...

Though the results aren’t definitive, it’s not premature to suggest high-risk individuals take shelter on very hot days.

CHICAGO, IL—For patients with a history of acute MI who are vulnerable to the cardiovascular risks posed by influenza ...

The mixed, counterintuitive results hinder trial interpretation, but along with ARREST-AF, experts still see actionable ...

In positive early data from the RCT, sacubitril/valsartan given over 24 weeks reduced signs of heart damage in cancer ...

HF specialists agree these drugs will be key tools in fighting the obesity-related HFpEF epidemic. Hurdles and questions ...